Description
Composition- Sitagliptin 100 mg + Metformin 1000 mg
Mode of Action- Combines incretin-based glucose regulation with metformin-mediated insulin sensitivity and reduced hepatic glucose output for comprehensive glycemic control.
USPs- Dual diabetes control; effective in fasting and postprandial glucose management; dependable fixed-dose combination.
Prescribing Specialties- Diabetologist, General Physician
